129 related articles for article (PubMed ID: 385191)
1. The complement system in bullous pemphigoid. VI. C3 fixing activity in the absence of detectable antibody.
Millns JL; Meurer M; Jordon RE
Clin Immunol Immunopathol; 1979 Aug; 13(4):475-83. PubMed ID: 385191
[No Abstract] [Full Text] [Related]
2. Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin.
Provost TT; Tomasi TB
Clin Exp Immunol; 1974 Oct; 18(2):193-200. PubMed ID: 4619597
[TBL] [Abstract][Full Text] [Related]
3. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
Jordon RE; Nordby JM; Milstein H
J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
[TBL] [Abstract][Full Text] [Related]
4. Immunologic phenomena in herpes gestationis.
Jablonska S; Chorzelski TP; Beutner EH; Maciejowska E; Rzesa G
Arch Dermatol Forsch; 1975 Jul; 252(4):267-74. PubMed ID: 1099991
[TBL] [Abstract][Full Text] [Related]
5. [The mechanism of antigen-antibody reaction at the basement membrane zone in bullous pemphigoid. The question of interaction of complement factors and bivalent cations (author's transl)].
Bockendahl H; Remy W; Stüttgen G; Petersen G
Arch Dermatol Res (1975); 1975 Dec; 254(2):135-42. PubMed ID: 56158
[TBL] [Abstract][Full Text] [Related]
6. [Herpes gestationis. Immunopathologic studies in mother and child].
Schöpf E; Seelig HP; Clorius R; Sheikh M; Bersch A
Hautarzt; 1976 Oct; 27(10):481-7. PubMed ID: 791898
[TBL] [Abstract][Full Text] [Related]
7. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
Provost TT; Tomasi TB
J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
[TBL] [Abstract][Full Text] [Related]
8. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
Suzuki M; Watanabe C; Yaoita H
Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
[TBL] [Abstract][Full Text] [Related]
10. The complement system in bullous pemphigoid: VII. Fixation of the regulatory protein beta 1H globulin by pemphigoid antibody.
Lee CW; Jordon RE
J Invest Dermatol; 1980 Dec; 75(6):465-9. PubMed ID: 6449528
[TBL] [Abstract][Full Text] [Related]
11. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
Kim Y; Vernier RL; Fish AJ; Michael AF
Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
[No Abstract] [Full Text] [Related]
13. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
Jordon RE; McDuffie FC
Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
[TBL] [Abstract][Full Text] [Related]
14. Deposition of the membrane attack complex of complement in bullous pemphigoid.
Dahl MV; Falk RJ; Carpenter R; Michael AF
J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
[TBL] [Abstract][Full Text] [Related]
15. [Immunopathological studies in bullous skin diseases].
Sysa-Jøedrzejowska A; Lutowiecka Wranicz A
Przegl Dermatol; 1979; 66(3):225-30. PubMed ID: 382265
[No Abstract] [Full Text] [Related]
16. Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor.
Carruthers JA; Ewins AR
Clin Exp Immunol; 1978 Jan; 31(1):38-44. PubMed ID: 346270
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.
Schroeter AL; Conn DL; Jordon RE
Ann Rheum Dis; 1976 Aug; 35(4):321-6. PubMed ID: 970989
[TBL] [Abstract][Full Text] [Related]
18. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of benign chronic bullous dermatosis of childhood.
Piamphongsant T; Charuworn A; Himmanknan P
J Med Assoc Thai; 1982 Feb; 65(2):106-8. PubMed ID: 7042887
[No Abstract] [Full Text] [Related]
20. Relationship of beta 1H globulin and cleavage fragments of the third component of complement in the skin of patients with bullous pemphigoid and dermatitis herpetiformis.
Gammon WR; Ruddy S; Sams MW; Carlo JR
Clin Immunol Immunopathol; 1981 Jul; 20(1):21-30. PubMed ID: 6167388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
